WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012109233) METHODS FOR PREDICTING RECURRENCE RISK IN BREAST CANCER PATIENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/109233    International Application No.:    PCT/US2012/024133
Publication Date: 16.08.2012 International Filing Date: 07.02.2012
IPC:
G01N 33/53 (2006.01), C12Q 1/68 (2006.01)
Applicants: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 201 West 7th St. Austin, TX 78701 (US) (For All Designated States Except US).
MILLS, Gordon, B. [CA/US]; (US) (For US Only).
JU, Zhenlin [US/US]; (US) (For US Only).
COOMBES, Kevin [US/US]; (US) (For US Only).
HENNESSY, Bryan [IE/IE]; (IE) (For US Only)
Inventors: MILLS, Gordon, B.; (US).
JU, Zhenlin; (US).
COOMBES, Kevin; (US).
HENNESSY, Bryan; (IE)
Agent: PARKER, David, L.; Parker Highlander, PLLC 1120 S. Capital of Texas Highway Building One, Suite 200 Austin, TX 78746 (US)
Priority Data:
61/440,213 07.02.2011 US
Title (EN) METHODS FOR PREDICTING RECURRENCE RISK IN BREAST CANCER PATIENTS
(FR) PROCÉDÉS DE PRÉDICTION DU RISQUE DE RÉCIDIVE CHEZ DES PATIENTS ATTEINTS D'UN CANCER DU SEIN
Abstract: front page image
(EN)The invention relates to methods and kits useful for predicting or assessing recurrence risk in a patient having breast cancer who has been administered or treated with an anti-estrogen drug. Protein marker panels and methods of using the expression levels of these protein markers in calculating cancer recurrence risk and likelihood of response to the treatment are provided.
(FR)L'invention concerne des procédés et des trousses utiles pour la prédiction ou l'estimation du risque de récidive chez un patient atteint d'un cancer du sein auquel on a administré ou que l'on a traité par un médicament anti-œstrogène. L'invention concerne des panels de marqueurs protéiques et des procédés d'utilisation des niveaux d'expression de ces marqueurs protéiques dans le calcul du risque de récidive du cancer et de la probabilité de réponse au traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)